P-42, r. 1 - Regulation respecting the administering of certain medications

Updated to 1 January 2024

This document has official status.

chapter P-42, r. 1

Regulation respecting the administering of certain medications

Animal Health Protection Act

(chapter P-42, s. 55.9).

1. No person may administer to bees sulfathiazole ((para-aminbenzene-sulfonamido) -2 thiazole), or its salts or derivatives.

O.C.1051-87, s. 1.

1.1. The administering, for curative purposes, of a medication belonging to one of the classes of antimicrobials of the “Category I: Very High Importance” to an animal intended or whose products are intended for human consumption is reserved exclusively to the cases in which it appears, for instance after carrying out an antibiogram, that the administering of a medication of a class other than the classes of that category will not allow treatment of the disease.

The term “classes of antimicrobials of the “Category I: Very High Importance”” refers to the classes published on the Health Canada website derived from the antimicrobial categorization based on the importance of those medications in human medicine.

O.C. 1110-2018, s. 1.

1.2. The administering, for preventive purposes, of a medication belonging to one of the classes of antimicrobials of the “Category I: Very High Importance” to an animal intended or whose products are intended for human consumption is prohibited.

The prohibition provided for in the first paragraph does not apply in the case of an animal that does not show any signs of disease if that animal is part of a restricted group including sick animals that may, in accordance with section 1.1, be treated using a medication belonging to one of the classes of antimicrobials of the “Category I: Very High Importance” and if there is a serious risk of propagation of the disease by reason of the proximity of the animals.

O.C. 1110-2018, s. 1.

1.3. The administering of a medication belonging to one of the classes of antimicrobials of the “Category I: Very High Importance” to embryonated poultry eggs is prohibited.

The administering of such medication to embryonated eggs from birds of a flock used to provide genetic material is allowed where the following conditions are present:

(a)  an infectious agent is present within the flock;

(b)  the propagation of the infectious agent to embryonated eggs poses a serious risk to the health of the bird stock or of humans;

(c)  treatment of the infected birds will not control the risk of propagation to embryonated eggs;

(d)  the administering of a medication of a class other than the “Category I: Very High Importance” will not eliminate the infectious agent.

O.C. 1110-2018, s. 1.

1.4. Every person who contravenes any of the provisions of this Regulation is liable to the penalty provided for in section 55.43 of the Animal Health Protection Act (chapter P-42).

O.C. 1110-2018, s. 1.

2. (Omitted).

O.C.1051-87, s. 2.

REFERENCES

O.C. 1051-87, 1987 G.O. 2, 2242

O.C. 1110-2018, 2018 G.O. 2, 4451